Metabolic disturbances and defects in insulin secretion in rats with streptozotocin-nicotinamide-induced diabetes

Physiological Research

Volumn 62, Issue 6, 2013, Pages 663-670

  Szkudelski, Tomasz ^a   Zywert, A ^a   Szkudelska, K ^a  

^a POZNA UNIVERSITY OF LIFE SCIENCES   (Poland)

Author keywords

Diabetes; Metabolism; Nicotinamide; Pancreatic islets; Rat; Streptozotocin

Indexed keywords

GLUCAGON; GLUCOSE; INSULIN; NICOTINAMIDE; STREPTOZOCIN;

ANIMAL; ARTICLE; BLOOD; CELL CULTURE; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; EXPERIMENTAL DIABETES MELLITUS; MALE; METABOLISM; PANCREAS ISLET BETA CELL; RAT; SECRETION (PROCESS); SEVERITY OF ILLNESS INDEX; WISTAR RAT;

ANIMALS; CELLS, CULTURED; DIABETES MELLITUS, EXPERIMENTAL; DISEASE MODELS, ANIMAL; GLUCAGON; GLUCOSE; INSULIN; INSULIN-SECRETING CELLS; MALE; NIACINAMIDE; RATS; RATS, WISTAR; SEVERITY OF ILLNESS INDEX; STREPTOZOCIN;

EID: 84891640029     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. AMERICAN DIABETES ASSOCIATION: Diagnosis and classification of diabetes mellitus. Diab Care 29: S43-S48, 2006.
2. BERGMEYER HU, BERNT E: D-glucose determination with glucose oxidase and peroxidase. In: Methods of Enzymatic Analysis. H. U. BERGMEYER (ed), Academic Press, New York, 1974, pp 1205-1215.
3. CHATZIGEORGIOU A, HALAPAS A, KALAFATAKIS K, KAMPER E: The use of animal models in the study of diabetes mellitus. In Vivo 23: 245-258, 2009.
4. DOLZ M, MOVASSAT J, BAILBé D, LE STUNFF H, GIROIX MH, FRADET M, KERGOAT M, PORTHA B: cAMP-secretion coupling is impaired in diabetic GK/Par rat ß-cells: a defect counteracted by GLP-1. Am J Physiol 301: E797-E806, 2011.
5. DUNCOMBE D: The colorimetric micro-determination of nonesteryfied fatty acids in plasma. Clin Chim Acta 9: 122- 125, 1964.
6. EVERSE J: Enzymic determination of lactic acid. Methods Enzymol 41: 41-44, 1975.
7. FAHIEN LA, MACDONALD MJ: The complex mechanism of glutamate dehydrogenase in insulin secretion. Diabetes 60: 2450-2454, 2011.
8. FIERABRACCI V, DE TATA V, POCAI A, NOVELLI M, BARBERA A, MASIELLO P: Oral tungstate treatment improves only transiently alteration of glucose metabolism in a new rat model of type 2 diabetes. Endocrine 19: 177-184, 2002.
9. FOLCH J, LEES M, SLOANE GSH: A simple method of the isolation and purification of total lipids from animal tissues. J Biol Chem 226: 497-509, 1975.
10. FOSTER LB, DUNN RT: Stable reagents for determination of serum triglycerides by a corotimetric Hatzsch condensation method. Clin Chem 19: 338-340, 1973.
11. HOLST JJ, GROMADA J: Role of incretin hormones in the regulation of insulin secretion in diabetic and nondiabetic humans. Am J Physiol 287: E199-E206, 2004.
12. JAIN SK, RAINS JL, CROAD JL: Effect of chromium niacinate and chromium picolinate supplementation on lipid peroxidation, TNF-alpha, IL-6, CRP, glycated hemoglobin, triglycerides, and cholesterol levels in blood of streptozotocin-treated diabetic rats. Free Radic Biol Med 43: 1124-1131, 2007.
13. JANJIC D, WOLLHEIM CB: Islet cell metabolism is reflected by the MTT (tetrazolium) colorimetric assay. Diabetologia 35: 482-485, 1992.
14. KING AJF: The use of animal models in diabetes research. Br J Pharmacol 166: 877-894, 2012.
15. LACY PE, KOSTIANOVSKY M: Method for the isolation of intact islets of Langerhans from the rat pancreas. Diabetes 16: 35-39, 1967.
16. LENZEN S: The mechanisms of alloxan- and streptozotocin-induced diabetes. Diabetologia 51: 216-226, 2008.
17. MASIELLO P: Animal models of type 2 diabetes with reduced pancreatic ß-cell mass. Int J Biochem Cell Biol 38: 873- 893, 2006.
18. MASIELLO P, BROCA C, GROSS R, ROYE M, MANTEGHETTI M, HILLAIRE-BUYS D, NOVELLI M, RIBES G: Experimental NIDDM: development of a new model in adult rats administered streptozotocin and nicotinamide. Diabetes 47: 224-229, 1998.
19. NOVELLI M, FABREGAT ME, FERNANDEZ-ALVAREZ J, GOMIS R, MASIELLO P: Metabolic and functional studies on isolated islets in a new rat model of type 2 diabetes. Mol Cell Endocrinol 175: 57-66, 2001.
20. NOVELLI M, POCAI A, LAJOIX AD, BEFFY P, BEZZI D, MARCHETTI P, GROSS R, MASIELLO P: Alteration of beta-cell constitutive NO synthase activity is involved in the abnormal insulin response to arginine in a new rat model of type 2 diabetes. Mol Cell Endocrinol 219: 77-82, 2004.
21. OKABAYASHI Y, OTSUKI M, OHKI A, TANI S, BABA S: Increased beta-cell secretory responsiveness to ceruletide and TPA in streptozocin-induced mildly diabetic rats. Diabetes 38: 1042-1047, 1989.
22. OLUKMAN M, SEZER ED, ULKER S, SOZMEN EY, CINAR GM: Fenofibrate treatment enhances antioxidant status and attenuates endothelial dysfunction in streptozotocin-induced diabetic rats. Exp Diabetes Res 2010: 1-10, 2010. doi: 10.1155/2010/828531
23. SZKUDELSKI T: The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiol Res 50: 537-546, 2001.
24. SZKUDELSKI T: Phytic acid-induced metabolic changes in the rat. J Anim Physiol Anim Nutr (Berl) 89: 397-402, 2005.
25. SZKUDELSKI T: Resveratrol inhibits insulin secretion from rat pancreatic islets. Eur J Pharmacol 552: 176-181, 2006.
26. SZKUDELSKI T: Resveratrol-induced inhibition of insulin secretion from rat pancreatic islets: evidence for pivotal role of metabolic disturbances. Am J Physiol 293: E901-E907, 2007.
27. SZKUDELSKI T: Streptozotocin-nicotinamide-induced diabetes in the rat. Characteristics of the experimental model. Exp Biol Med 237: 481-490, 2012.
28. ZYWERT A, SZKUDELSKA K, SZKUDELSKI T: Effects of adenosine A1 receptor antagonism on insulin secretion from rat pancreatic islets. Physiol Res 60: 905-911, 2011.